Automatically diagnosing HER2 amplification status for breast cancer patients using large FISH images
暂无分享,去创建一个
[1] John M S Bartlett,et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. , 2014, Archives of pathology & laboratory medicine.
[2] T. Lörch,et al. Automated fluorescent in situ hybridization (FISH) analysis of t(9;22)(q34;q11) in interphase nuclei , 2006, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[3] Anthony Rhodes,et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). , 2010, Archives of pathology & laboratory medicine.
[4] Jean-Marc Guinebretière,et al. SISH/CISH or qPCR as alternative techniques to FISH for determination of HER2 amplification status on breast tumors core needle biopsies: a multicenter experience based on 840 cases , 2013, BMC Cancer.
[5] G Konecny,et al. The molecular and cellular biology of HER2/neu gene amplification/overexpression and the clinical development of herceptin (trastuzumab) therapy for breast cancer. , 2000, Cancer treatment and research.
[6] A D Carothers,et al. Counting, measuring, and mapping in FISH-labelled cells: sample size considerations and implications for automation. , 1994, Cytometry.
[7] K McPherson,et al. ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. , 2000, BMJ.
[8] Feng Jiang,et al. Use of Interphase Fluorescence In Situ Hybridization as a Powerful Diagnostic Tool in Cytology , 2002, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[9] Anthony Rhodes,et al. American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] Mitch Dowsett,et al. HER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneity , 2014, Modern Pathology.
[11] Ioannis Pitas,et al. Automated evaluation of her-2/neu status in breast tissue from fluorescent in situ hybridization images , 2005, IEEE Transactions on Image Processing.
[12] Bin Zheng,et al. Automated Analysis of Fluorescent in situ Hybridization (FISH) Labeled Genetic Biomarkers in Assisting Cervical Cancer Diagnosis , 2010, Technology in cancer research & treatment.
[13] M. Berger,et al. Lapatinib plus capecitabine for HER2-positive advanced breast cancer. , 2006, The New England journal of medicine.